Complement activation by RPE cells preexposed to TNFα and IFNγ.
Complement
Interferons
Membrane attack complex
Retinal pigment epithelium
Tumor necrosis factor
Journal
Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
06
10
2021
revised:
08
02
2022
accepted:
14
02
2022
pubmed:
21
2
2022
medline:
28
4
2022
entrez:
20
2
2022
Statut:
ppublish
Résumé
Age-related macular degeneration (AMD) has been associated with both complement activation and increased levels of circulating cytokines. Here, we sougth to investigate if cytokine-preexposure of retinal pigment epithelial (RPE) leads to increased complement activation and deposition of membrane attack complex (MAC). Primary human RPE and the ARPE19 cell line cultured in serum-free conditions were preexposed to 100 ng/ml interferon-gamma (IFNγ) and 20 ng/ml tumor necrosis factor-alpha (TNFα) for 48 h followed by exposure to diluted serum from healthy donors or complement factor B deficient (CFBd) serum for 70 min. Deposition of membrane attack complexes (MAC) was examined by use of a MAC-ELISA kit and by immunofluorescence. Eculizumab (anti-C5) was examined for its ability to prevent deposition of MAC on RPE cells exposed to serum. Lactatdehydrogenase (LDH) and thiazolyl blue tetrazolium bromide (MTT) assays were used to assess cellular metabolism and survival. MAC was deposited only on RPE preexposed to both IFNγ and TNFα. Lack of complement factor B or inhibition of C5 abrogated the MAC-deposition on RPE cells, while reconstitution of CFBd serum with CFB resulted in MAC-deposition. MAC-deposition resulted in RPE-release of LDH, but unaltered mitochondrial activity estimated by MTT. We conclude that preexposure of primary RPE and ARPE19 with inflammatory cytokines promoted alternative pathway activation of complement and deposition of MAC. This implies that circulating inflammatory mediators may increase susceptibility to local complement activation and MAC-deposition, which may represent an early event in the pathogenesis leading to AMD development.
Identifiants
pubmed: 35183540
pii: S0014-4835(22)00063-X
doi: 10.1016/j.exer.2022.108982
pii:
doi:
Substances chimiques
Complement Membrane Attack Complex
0
Retinal Pigments
0
Tumor Necrosis Factor-alpha
0
Interferon-gamma
82115-62-6
Complement Factor B
EC 3.4.21.47
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108982Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.